Daxxify: Recommendations for Treatment: How and When to Change a Patient from One Neurotoxin to Another. // Advances in Cosmetic Surgery. – URL: https://www.sciencedirect.com/science/article/pii/S2542432723000395?dgcid=rss_sd_all
Daxxify: Recommendations for Treatment: How and When to Change a Patient from One Neurotoxin to Another. Advances in Cosmetic Surgery. https://www.sciencedirect.com/science/article/pii/S2542432723000395?dgcid=rss_sd_all
“Daxxify: Recommendations for Treatment: How and When to Change a Patient from One Neurotoxin to Another.” Advances in Cosmetic Surgery.
@article{article33555,
title = {Daxxify: Recommendations for Treatment: How and When to Change a Patient from One Neurotoxin to Another},
journal = {Advances in Cosmetic Surgery},
url = {https://www.sciencedirect.com/science/article/pii/S2542432723000395?dgcid=rss_sd_all}
}
ABSTRACT Cutaneous squamous cell carcinoma (cSCC) is a leading cause of cancer‐related morbidity and mortality in solid organ transplant recipients (SOTRs). Immune checkpoint inhibitors (ICIs) targeting programmed death receptor‐1...